TDAG51 Attenuates Impaired Lipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus Through SREBP-1/ANGPTL8 Pathway


Journal

Balkan medical journal
ISSN: 2146-3131
Titre abrégé: Balkan Med J
Pays: Turkey
ID NLM: 101571817

Informations de publication

Date de publication:
08 05 2023
Historique:
medline: 11 5 2023
entrez: 24 3 2023
pubmed: 25 3 2023
Statut: ppublish

Résumé

T-cell death-associated gene 51 (TDAG51) belongs to the transcription factor family and is involved in the energy homeostasis of the liver through the regulation of lipogenesis. To evaluate the role of T-cell death-associated gene 51 in gestational diabetes mellitus. Experimental animal and human-sample study. A total of 30 patients with GDM were enrolled in the study. TDAG51 expression in patients with gestational diabetes mellitus was assessed by Western blotting and quantitative reverse-transcription polymerase chain reaction. A high-fat and high-sugar diet was used to establish a gestational diabetes mellitus model. Mice with gestational diabetes were injected with lentivirus-mediated overexpression of TDAG51. Blood glucose was measured using a glucometer, and glucose and insulin tolerance tests were performed to detect insulin resistance. Liver and adipose tissues were subjected to hematoxylin-eosin staining. Cell apoptosis was detected by TUNEL staining. Human villous trophoblast cells (HTR-8/SVneo) were treated with a high-glucose medium to induce gestational diabetes mellitus. TDAG51 was downregulated in gestational diabetes mellitus and high glucose-induced HTR-8/SVneo. TDAG51 overexpression reduced the level of blood glucose, enhanced serum insulin, and attenuated glucose and insulin tolerance in gestational diabetes mellitus mice. TDAG51 overexpression also ameliorated impaired lipid metabolism and alleviated adipocyte hypertrophy and hepatic lipid droplets in gestational diabetes mellitus mice. The expressions of SREBP-1 and ANGPTL8 were upregulated in gestational diabetes mellitus and showed a negative correlation with TDAG51 in patients with gestational diabetes mellitus. TDAG51 increased the expressions of SREBP-1 and ANGPTL8 in gestational diabetes mellitus mice. TDAG51 overexpression reduced cell apoptosis and enhanced cell viability of high glucose-induced HTR-8/SVneo. Ectopic expression of ANGPTL8 attenuated the TDAG51-induced increase in cell viability and decrease in apoptosis in high glucose-induced HTR-8/SVneo. TDAG51 alleviated impaired lipid metabolism and insulin resistance in gestational diabetes mellitus via downregulation of SREBP 1/ANGPTL8 pathway.

Sections du résumé

Background
T-cell death-associated gene 51 (TDAG51) belongs to the transcription factor family and is involved in the energy homeostasis of the liver through the regulation of lipogenesis.
Aims
To evaluate the role of T-cell death-associated gene 51 in gestational diabetes mellitus.
Study Design
Experimental animal and human-sample study.
Methods
A total of 30 patients with GDM were enrolled in the study. TDAG51 expression in patients with gestational diabetes mellitus was assessed by Western blotting and quantitative reverse-transcription polymerase chain reaction. A high-fat and high-sugar diet was used to establish a gestational diabetes mellitus model. Mice with gestational diabetes were injected with lentivirus-mediated overexpression of TDAG51. Blood glucose was measured using a glucometer, and glucose and insulin tolerance tests were performed to detect insulin resistance. Liver and adipose tissues were subjected to hematoxylin-eosin staining. Cell apoptosis was detected by TUNEL staining. Human villous trophoblast cells (HTR-8/SVneo) were treated with a high-glucose medium to induce gestational diabetes mellitus.
Results
TDAG51 was downregulated in gestational diabetes mellitus and high glucose-induced HTR-8/SVneo. TDAG51 overexpression reduced the level of blood glucose, enhanced serum insulin, and attenuated glucose and insulin tolerance in gestational diabetes mellitus mice. TDAG51 overexpression also ameliorated impaired lipid metabolism and alleviated adipocyte hypertrophy and hepatic lipid droplets in gestational diabetes mellitus mice. The expressions of SREBP-1 and ANGPTL8 were upregulated in gestational diabetes mellitus and showed a negative correlation with TDAG51 in patients with gestational diabetes mellitus. TDAG51 increased the expressions of SREBP-1 and ANGPTL8 in gestational diabetes mellitus mice. TDAG51 overexpression reduced cell apoptosis and enhanced cell viability of high glucose-induced HTR-8/SVneo. Ectopic expression of ANGPTL8 attenuated the TDAG51-induced increase in cell viability and decrease in apoptosis in high glucose-induced HTR-8/SVneo.
Conclusion
TDAG51 alleviated impaired lipid metabolism and insulin resistance in gestational diabetes mellitus via downregulation of SREBP 1/ANGPTL8 pathway.

Identifiants

pubmed: 36960944
doi: 10.4274/balkanmedj.galenos.2023.2022-8-61
pmc: PMC10175879
doi:

Substances chimiques

Blood Glucose 0
Sterol Regulatory Element Binding Protein 1 0
Glucose IY9XDZ35W2
Insulins 0
ANGPTL8 protein, human 0
Angiopoietin-Like Protein 8 0
Peptide Hormones 0
ANGPTL8 protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-181

Références

Nutr Diabetes. 2019 Oct 7;9(1):28
pubmed: 31591391
Trends Endocrinol Metab. 2018 Nov;29(11):743-754
pubmed: 30297319
Diabetes. 2013 Jan;62(1):158-69
pubmed: 22961087
Biomed Pharmacother. 2016 Dec;84:1460-1465
pubmed: 27810341
Front Endocrinol (Lausanne). 2021 Jun 08;12:635321
pubmed: 34163433
J Biol Chem. 2014 Feb 28;289(9):5510-7
pubmed: 24398675
Cell Physiol Biochem. 2015;36(2):542-54
pubmed: 25997527
Mol Cell Biol. 2001 Dec;21(24):8365-70
pubmed: 11713273
Int J Endocrinol. 2022 Apr 26;2022:1113811
pubmed: 35529083
Medicine (Baltimore). 2019 Apr;98(16):e15320
pubmed: 31008986
PLoS Genet. 2019 Jun 28;15(6):e1008214
pubmed: 31251738
Mol Cell Endocrinol. 2015 Oct 15;414:148-55
pubmed: 26254015
Open Biol. 2021 Sep;11(9):210106
pubmed: 34582711
J Neonatal Perinatal Med. 2020;13(4):529-541
pubmed: 31903997
Cardiorenal Med. 2012 May;2(2):134-142
pubmed: 22851962
Nat Rev Endocrinol. 2018 Feb;14(2):64
pubmed: 29219150
Cell Death Dis. 2021 Oct 8;12(10):921
pubmed: 34625532
J Pharmacol Exp Ther. 2021 Apr;377(1):146-156
pubmed: 33509902
Trends Biochem Sci. 2018 May;43(5):358-368
pubmed: 29500098
Biomed Pharmacother. 2021 Nov;143:112183
pubmed: 34560536
Ann N Y Acad Sci. 2002 Jun;967:19-27
pubmed: 12079831
PLoS One. 2018 May 3;13(5):e0196704
pubmed: 29723221
Evid Based Complement Alternat Med. 2021 Oct 05;2021:6813147
pubmed: 34650614

Auteurs

Xiaozhi Wu (X)

Department of Obstetrics, The First People’s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China

Biru Xiao (B)

Department of Obstetrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH